AJMC - The American Journal of Managed Care’s Post

[Inno 360°] Side Onco Skin is a tool for oncology and dermatology professionals worldwide, developed in partnership with Eau Thermale Avène and specialized onco-dermatologists Pr.Caroline Knebelman-Robert (Gustave Roussy institute) and Dr.Vincent SIBAUD (IUCT-Oncopole) 🔍 Managing dermatological toxicities associated with anti-cancer treatments is paramount for oncologists and dermatologists. This is why the Side Onco Skin directory was created: to assist healthcare professionals in identifying and treating such side effects. This unique platform allows: 👉 Rapid identification and explanation of conditions for patients through pictures. 👉 A user-friendly interface for quick access to information on a wide range of symptoms. 👉 Regular contributions from leading experts, such as Prof. Vincent Sibaud. 👉 Interactive tests to track knowledge progression in an engaging and educational way. Another innovative advance in the field of #OncoDermatology. #PierreFabre #NewWaysToCare #Oncology #Dermatology #PatientCare #MedicalApp #Avene 

🔥 In-Depth Insight from EADV 2024! Prof. Dr. Jan Gutermuth from the University Hospital Brussels shares his insights on:  1️⃣ Whether patients with BP should undergo routine cancer screening. 2️⃣ The current and future need for in-patient dermatology beds in light of new treatments and surgical advancements. Discover these updates.👇 For all EADV 2024 videos, find the link in the comments! #MediMix #EADV2024 #Dermatology #MedicalResearch #DermatologyAdvancements 

It's today! Join us from 1:00 – 2:00 pm CET and learn more about Recent findings on “GNAQ/GNA11 Mosaicism Causes Aberrant Calcium Signaling Susceptible to Targeted Therapeutics.” Access the meeting here: https://lnkd.in/dsF8txF #ernskin #webinar #europeanreferencenetworks #MOSAIC #rareskin #Mosaicism #therapeutics #dermatology

This event has been postponed, new dates to follow. Looking forward to having Keith Loo from Skinopathy speak at our "Canada's MedTech Research Event" his educational talk: "AI in MedTech: Reshaping Dermatology & Oncology Healthcare" Learning Objectives:  1. Review the concept and development stage of Skinopathy-an AI Medtech Diagnostic Device including implementing practical use in real world settings  2. Discuss the regulatory approval & commercialization path  3. Discuss addressing the dermatology gap of assessing & diagnosis of skin disease in Skin of Colour (SOC) Learning objective three is very interesting as a previous study found 47% of dermatologists felt training was inadequate to diagnose disease in skin of colour patients Kim McDonald-Taylor Jaspreet K Grewal, MBA Adrijana D'Silva Alex Karabanow 🌍 🍁 🇨🇭 Angelina Brathwaite Robert Tam Sharareh Hosseinzadeh Mo Amin Jen Belcher Nate Stepner David Warwick Frank Shannon #medtech #devices #dermatology #oncology #clinicaltrials #clinicalresearch #medicaldevices #healthcanada #AI #Canada #diagnostics

Thrilled to announce the publication of our latest article, "No increased risk of breast or gynecologic malignancies in women exposed to spironolactone for dermatological conditions: a retrospective cohort study" in the Journal of the American Academy of Dermatology (JAAD)! 📚 "Spironolactone is a blood pressure and congestive heart failure medication used off-label for treatment of dermatological conditions in women. As per a Food and Drug Administration warning included in the package insert, rat studies showed tumorigenicity with high oral spironolactone doses. Due to antiandrogen properties and structural similarity to estrogen, it has been hypothesized that spironolactone may increase breast/gynecologic cancer risk. Therefore, we examined whether spironolactone exposure for acne, hair loss, and/or hirsutism indications is associated with increased breast and/or gynecologic tumor risk." Huge thanks to my amazing coauthors for their hard work and dedication! Check out the article here: [https://lnkd.in/dy8-dPEV] #Research #Publication #PHS #Biostatistics #Dermatology #Spironolactone #Retrospective-study

Which medical specialties do you think are most researched? M3’s panel team recently shared a blog highlighting the top six specialties that are currently in high demand for paid surveys. Topping the list are: 1. Oncology and haematology 2. Cardiology 3. Dermatology Find out which other specialties made the top spots and what impacts the availability of paid medical surveys > https://hubs.ly/Q02sGJCf0 #Marketresearch #Healthcare #MedicalSpecialties #Paidsurveys #Oncology #Haematology #Cardiology #Dermatology

Dr Ashley O'Toole and Dr Melinda Gooderham in Vienna, Austria 🇦🇹 with a group of Canadian delegates to discuss atopic dermatitis, prurigo nodularis and Type 2 inflammation with global colleagues. 👍 This was an excellent opportunity for them to brush up on their presentation skills and exchange insights and their clinical trial experience with dupilumab with international experts in the field. #dermatology #globalcollaboration #Type2inflammation #atopicdermatitis #prurigonodularis

🧬#MolecularDiagnostics of inflammatory skin diseases in difficult to distinguish cases enables evaluation of tissue samples #BeyondTheSurface. DNA and RNA based tests will improve precision in diagnostics, unfold the full potential of specific therapeutics and thus improve patient care. You want to join our journey of #MovingDiagnosticFrontiers in dermatology? Stay fully informed about the latest advancements in molecular diagnostics in dermatology by subscribing to our forthcoming newsletter. Receive updates on our newest publications, events, and much more: https://lnkd.in/esGZt8MZ #Dermatology #Psoriasis #Eczema #Newsletter #SubscribeNow

Transcriptomics: A "Game Changer" in Managing Severe Inflammatory Skin Diseases We are pleased to announce a recent article co-authored by Emmanuel Contassot from the Navarini Lab at the Department of Biomedicine in Sciences Advances (Science Magazine). In this publication, their team – in collaboration with Dr. Antonios Kolios from the Dermatology Department at Universitätsspital Zürich – analyzed transcriptomic data from Pityriasis rubra pilaris (PRP) patients. PRP is a severe inflammatory skin condition that significantly reduces quality of life. Their precision medicine approach revealed IL-1β as a key driver in PRP, leading to successful treatment of three therapy-resistant patients using IL-1β antagonists, anakinra and canakinumab. All patients showed rapid and significant improvements, highlighting how transcriptomics can be a “game changer” in managing severe inflammatory skin diseases. Congratulations to everyone involved in these groundbreaking findings. Publication Link: https://lnkd.in/e8iCeDXH #PrecisionMedicine #Dermatology #TranslationalResearch #Collaboration #Inflammation #PRP

Today, UCB announced they have received a positive CHMP opinion for Bimzelx (bimekizumab) in the EU for the treatment of moderate to severe hidradenitis suppurativa (HS) in adults with an inadequate response to conventional systemic HS therapy.   The positive CHMP opinion is based on the Phase 3 BE HEARD I and BE HEARD II studies, resulting in statistically significant and clinically meaningful improvements of bimekizumab over placebo in the signs and symptoms of HS.   If approved, bimekizumab will be the first IL-17F and IL-17A inhibitor to treat adults with moderate to severe HS in the EU, adding to its existing approvals for psoriasis (PSO), psoriatic arthritis (PsA), and ankylosing spondylitis (AS).   Read More: https://lnkd.in/ef4jc8ss   #Dermatology #HidradenitisSuppurativa #HS #UCB #Bimzelx